Moreover, TEFM expression was found to correlate with the clinicopathological T-stage of NSCLC, with higher expression observed in patients with T4 stage compared to those with T1 stage (Fig. 1C). The gene discussed is TEFM; the disease is non-small cell lung carcinoma.